Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.

作者信息

Sirois Caroline, Moisan Jocelyne, Poirier Paul, Grégoire Jean-Pierre

机构信息

Faculty of Pharmacy, Laval University, Quebec, Canada.

出版信息

Diabetes Care. 2007 Jul;30(7):1880-2. doi: 10.2337/dc06-2257. Epub 2007 Mar 23.

DOI:10.2337/dc06-2257

PMID:17384345

Abstract

摘要

相似文献

Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.

Diabetes Care. 2007 Jul;30(7):1880-2. doi: 10.2337/dc06-2257. Epub 2007 Mar 23.

Association between age and the initiation of antihypertensive, lipid lowering and antiplateletet medications in elderly individuals newly treated with antidiabetic drugs.

Age Ageing. 2009 Nov;38(6):741-5. doi: 10.1093/ageing/afp170. Epub 2009 Sep 16.

Underuse of cardioprotective treatment by the elderly with type 2 diabetes.

Diabetes Metab. 2008 Apr;34(2):169-76. doi: 10.1016/j.diabet.2007.12.004.

Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.

Metab Syndr Relat Disord. 2009 Apr;7(2):79-81. doi: 10.1089/met.2008.0092.

Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes.

Int J Clin Pract. 2006 Apr;60(4):422-8. doi: 10.1111/j.1368-5031.2006.00799.x.

[Prevention of ischemic cardiovascular complications in type 2 diabetes].

Journ Annu Diabetol Hotel Dieu. 2000:125-37.

Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.

Prim Care Diabetes. 2016 Aug;10(4):237-43. doi: 10.1016/j.pcd.2015.11.002. Epub 2015 Dec 1.

Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?

Diabetes Metab. 2006 Dec;32(6):559-67. doi: 10.1016/S1262-3636(07)70310-5.

[Arterial risk in type 2 diabetes: from mega-trials to prescription].

Rev Prat. 2003 May 15;53(10):1095-101.

Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.

Cardiovasc J Afr. 2009 Jan-Feb;20(1):73-4.

引用本文的文献

Variation in Patient-Described Barriers to and Facilitators of Diabetes Management by Individual-Level Characteristics: A Cross-Sectional, Open-Ended Survey.

Clin Diabetes. 2022 Summer;40(3):283-296. doi: 10.2337/cd21-0060.

Barriers to care in patients with diabetes and poor glycemic control-A cross-sectional survey.

PLoS One. 2017 May 1;12(5):e0176135. doi: 10.1371/journal.pone.0176135. eCollection 2017.

Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001.

Can J Cardiol. 2010 Dec;26(10):523-31. doi: 10.1016/s0828-282x(10)70465-7.

Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial.

Trials. 2010 Apr 23;11:44. doi: 10.1186/1745-6215-11-44.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验